共 11 条
- [1] Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial[J]. EBIOMEDICINE, 2015, 2 (12): : 1965 - 1973Azria, DavidRiou, OlivierCastan, FlorenceTan Dat NguyenPeignaux, KarineLemanski, ClaireLagrange, Jean-LeonKirova, YouliaLartigau, EricBelkacemi, YazidBourgier, CelineRivera, SofiaNoel, GeorgesClippe, SebastienMornex, FrancoiseHennequin, ChristopheKramar, AndrewGourgou, SophiePelegrin, AndreFenoglietto, PascalOzsahin, Esat Mahmut
- [2] Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial[J]. LANCET, 2020, 395 (10237) : 1613 - 1626Brunt, Adrian MurrayHaviland, Joanne S.Wheatley, Duncan A.Sydenham, Mark A.Alhasso, AbdullaBloomfield, David J.Chan, CharlieChurn, MarkCleator, SusanColes, Charlotte E.Goodman, AndrewHarnett, AdrianHopwood, PenelopeKirby, Anna M.Kirwan, Cliona C.Morris, CarolynNabi, ZohalSawyer, ElinorSomaiah, NavitaStones, LibaSyndikus, IsabelBliss, Judith M.Yarnold, John R.
- [3] International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic[J]. CLINICAL ONCOLOGY, 2020, 32 (05) : 279 - 281Coles, C. E.Aristei, C.Bliss, J.Boersma, L.Brunt, A. M.Chatterjee, S.Hanna, G.Jagsi, R.Person, O. KaidarKirby, A.Mjaaland, I.Meattini, I.Luis, A. M.Marta, G. N.Offersen, B.Poortmans, P.Rivera, S.
- [4] Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) : 987 - 998Darby, Sarah C.Ewertz, MarianneMcGale, PaulBennet, Anna M.Blom-Goldman, UllaBronnum, DortheCorrea, CandaceCutter, DavidGagliardi, GiovannaGigante, BrunaJensen, Maj-BrittNisbet, AndrewPeto, RichardRahimi, KazemTaylor, CarolynHall, Per
- [5] Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy[J]. RADIOTHERAPY AND ONCOLOGY, 2007, 82 (03) : 254 - 264Donovan, EllenBleakley, NatalieDenholm, EricaEvans, PhilGothard, LoneHanson, JanePeckitt, ClareReise, StephanieRoss, GillSharp, GraceSymonds-Tayler, RichardTait, DianaYarnold, John
- [6] The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. LANCET ONCOLOGY, 2013, 14 (11) : 1086 - 1094Haviland, Joanne S.Owen, J. RogerDewar, John A.Agrawal, Rajiv K.Barrett, JaneBarrett-Lee, Peter J.Dobbs, H. JaneHopwood, PenelopeLawton, Pat A.Magee, Brian J.Mills, JudithSimmons, SandraSydenham, Mark A.Venables, KarenBliss, Judith M.Yarnold, John R.
- [7] Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. LANCET ONCOLOGY, 2019, 20 (01) : 88 - 99Mamounas, Eleftherios P.Bandos, HannaLembersky, Barry C.Jeong, Jong-HyeonGeyer, Charles E., Jr.Rastogi, PriyaFehrenbacher, LouisGraham, Mark L.Chia, Stephen K.Brufsky, Adam M.Walshe, Janice M.Soori, Gamini S.Dakhil, Shaker R.Seay, Thomas E.Wade, James L., IIIMcCarron, Edward C.Paik, SoonmyungSwain, Sandra M.Wickerham, D. LawrenceWolmark, Norman
- [8] REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer[J]. RADIOTHERAPY AND ONCOLOGY, 2019, 138 : 59 - 67Seibold, PetraWebb, AdamAguado-Barrera, Miguel E.Azria, DavidBourgier, CelineBrengues, MurielBriers, ErikBultijnck, ReneeCalvo-Crespo, PatriciaCarballo, AnaChoudhury, AnanyaCicchetti, AlessandroClassen, JohannesDelmastro, ElenaDunning, Alison M.Elliott, Rebecca M.Fachal, LauraFarcy-Jacquet, Marie-PierreGabriele, PietroGaribaldi, ElisabettaGomez-Caamano, AntonioGutierrez-Enriquez, SaraHigginson, Daniel S.Johnson, KerstieLobato-Busto, RamonMolla, MeritxellMueller, AnushaPayne, DebbiePeleteiro, PaulaPost, GiselleRancati, TizianaRattay, TimReyes, VictoriaRosenstein, Barry S.De Ruysscher, DirkDe Santis, Maria CarmenSchaefer, JoergSchnabel, ThomasSperk, ElenaSymonds, R. PaulStobart, HilaryTaboada-Valladares, BegonaTalbot, Christopher J.Valdagni, RiccardoVega, AnaVeldeman, LivWard, TimWeissenberger, ChristianWest, Catharine M. L.Chang-Claude, Jenny
- [9] Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (35) : 3340 - +Sjostrom, MartinChang, S. LauraFishbane, NickDavicioni, ElaiZhao, Shuang G.Hartman, LindaHolmberg, ErikFeng, Felix Y.Speers, Corey W.Pierce, Lori J.Malmstrom, PerFerno, MartenKarlsson, Per
- [10] Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial[J]. LANCET ONCOLOGY, 2019, 20 (03) : 352 - 360Wang, Shu-LianFang, HuiSong, Yong-WenWang, Wei-HuHu, ChenLiu, Yue-PingJin, JingLiu, Xin-FanYu, Zi-HaoRen, HuaLi, NingLu, Ning-NingTang, YuTang, YuanQi, Shu-NanSun, Guang-YiPeng, RanLi, ShuaiChen, BoYang, YongLi, Ye-Xiong